TEMPLE CITY, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing ...
Note: The Company made certain reclassifications to the prior years' financial statements to conform them to the presentation as of and for the year ended December 31, 2019 that management has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results